Key Takeaways:
-
The Dexcom G7 offers a smaller, sleeker design, faster 30-minute sensor warm-up, and an integrated transmitter-sensor system for easier use. It also provides enhanced glucose reading accuracy and sensor wear time of up to 10 days, plus a 12-hour grace period as an added convenience.
-
The Dexcom G7 is compatible with Apple Watch and other smart devices, allowing seamless monitoring. It also includes a more user-friendly mobile app with customizable alerts and a convenient wear location at the rear of the upper arm.
-
The Dexcom G7 can be significantly more affordable with insurance, potentially reducing out-of-pocket costs. Aeroflow Diabetes simplifies the process of obtaining the Dexcom G7 through insurance, ensuring quick delivery of supplies.
The Dexcom G7 is revolutionizing continuous glucose monitoring (CGM) with its enhanced features and design updates, providing better diabetes management tools for users. Dexcom built upon the success of its predecessor, the Dexcom G6, with significant improvements that make it one of the most advanced CGMs available.
The Dexcom G7 has a:
-
Smaller, sleeker design.
-
Faster sensor warm-up.
-
Transmitter and sensor combined into one system.
-
Compatibility with Apple Watch and other smart devices.
-
Improved glucose reading accuracy.
Dexcom G7 Release Date
The Dexcom G7 received FDA approval in the United States in December 2022, following its earlier release in Europe. It became available for purchase in the U.S. on February 17, 2023.
If you haven’t upgraded yet, now is a great time to explore its benefits.
What's New With the Dexcom G7?
The Dexcom G7 Continuous Glucose Monitor has many new features and updates compared to the Dexcom G6 and many other diabetes technology devices on the market.
Along with no fingersticks, the Dexcom G7 CGM will have the following updates and improvements:
-
A smaller, sleeker design that is 60% smaller than the G6, reducing the likelihood of snagging on clothing.
-
A faster 30-minute sensor warm-up, the quickest in the CGM market, providing near-instant access to glucose readings.
-
An all-in-one integrated system combining the transmitter and sensor for simplified use.
-
Compatibility with Apple Watch and other smart devices for seamless monitoring.
-
Improved glucose reading accuracy with a MARD of 8.2% when worn on the upper arm, offering reliable results even in the first 24 hours.
-
A wear time of up to 10 days per sensor, with an additional 12-hour grace period offering more convenient replacement options.
-
Enhancements to the user-friendly mobile app include brighter screens, faster calibration, and live integration with other apps for comprehensive monitoring.
-
Silent and customizable alert settings to minimize disruptions and improve user experience.
-
Improved wear locations in the rear of the upper arm, and upper buttocks for children, for more flexibility.
For a detailed breakdown of the new features and upgrades, check out our full comparison of the Dexcom G6 vs Dexcom G7.
Check your coverage for continuous glucose monitoring supplies through your insurance now!
Check your coverage for continuous glucose monitoring supplies through your insurance now!
Dexcom G7 Price
The price of the Dexcom G7 depends on whether you have insurance coverage:
-
Without insurance: Paying out of pocket for the Dexcom G7 sensor and supplies may cost around $3,800 per year, similar to the Dexcom G6.
-
With insurance: Many patients can significantly reduce costs through their insurance, often paying only a fraction of the total price.
Aeroflow Diabetes can help you determine the price you will pay for the Dexcom G7 with insurance, or guide you to affordable options if you’re paying out of pocket. Reach out today to learn more about how to minimize your cost.
How to Get the Dexcom G7 Through Insurance
Aeroflow Diabetes makes it easy to qualify for the Dexcom G7 through insurance. Here’s how:
-
If you’re upgrading from the Dexcom G6: If you currently use the Dexcom G6 with Aeroflow Diabetes and your insurance plan, transitioning to the Dexcom G7 is straightforward. Most users won’t need a new prescription unless their current one is nearing expiration.
-
For new users: First, you’ll need a prescription for your CGM from your healthcare provider. After you have your prescription, Aeroflow Diabetes simplifies the qualification process with our online form that takes less than five minutes to complete. Once approved, your Dexcom G7 sensor supplies will be delivered directly to your door without hassle.
Aeroflow Diabetes helps you access the Dexcom G7 at an affordable cost through insurance. Our quick and easy qualification process ensures you get your supplies delivered straight to your door without the hassle of pharmacy trips. Plus, we send reminders to help you stay stocked on your CGM supplies.
Fill out our simple Eligibility Form today to see if you’re eligible to receive this state-of-the-art CGM through your insurance plan.
Karen Case, Accuracy Reviewer & Continuous Glucose Monitor Specialist
Karen Case has a passion for working in the healthcare industry, understanding medicine, diabetes, and diseases. She holds an Associate’s degree in Medical Assisting and worked as the Head of Triage at Asheville Endocrinology for 10 years where she learned everything she could about diabetes, thyroid issues, and other endocrine issues. Karen currently works as the Continuous Glucose Monitor Specialist at Aeroflow Diabetes where she educates patients around the topics of diabetes, medications, continuous glucose monitors, pumps, insulin, and more.
About the Author
Julia Dietrich is the Marketing Coordinator at Aeroflow Diabetes. A graduate of Kean University with a Bachelor’s degree in Advertising, Julia has contributed to many marketing campaigns across different industries and understands well how important diabetes prevention, management, and education are for overall health and wellness.
Outside of her work, Julia enjoys photography, cooking, and spending time with family. Her background in marketing and dedication to patient advocacy and wellness, coincide with her commitment to educate and promote diabetes management.
References:
Dexcom G7 Receives CE Mark – Next-Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management | DexCom, Inc. (n.d.). Investors.dexcom.com. https://investors.dexcom.com/news-releases/news-release-details/dexcom-g7-receives-ce-mark-next-generation-continuous-glucose
Dexcom G7: Get Ready for the Next Gen. (2021, March 10). Taking Control of Your Diabetes. https://tcoyd.org/2021/03/the-next-gen-dexcom-g7/
An Inside Look at the Dexcom G7. (2022, March 21). DiaTribe. https://diatribe.org/inside-look-at-dexcom-g7#:~:text=The%20Dexcom%20G7%20features%20several
Dexcom CEO Sayer on G7 FDA submission, developing a 15-day sensor, M&A plans. (n.d.). MedTech Dive. Retrieved June 9, 2022, from https://www.medtechdive.com/news/dexcom-ceo-g7-fda-15-day-sensor-ma/625013/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue:%202022-06-08%20MedTech%20Dive%20%5Bissue:42297%5D&utm_term=MedTech%20Dive
Aeroflow Diabetes Disclaimer
Information provided on the Aeroflow Diabetes website is not intended as a substitute for medical advice or care from a healthcare professional. Aeroflow recommends consulting your healthcare provider if you are experiencing medical issues relating to diabetes care.
Validate your login